Supplier K

KAPA Biosystems is a leading life science tools company that specializes in the development of high-performance reagents for molecular biology applications, particularly Next-Generation Sequencing (NGS) and PCR. The company utilizes a proprietary directed evolution technology platform to engineer next-generation enzymes, such as DNA polymerases and reverse transcriptases, that offer improved speed, sensitivity, and tolerance to inhibitors. Its product portfolio includes library preparation kits, high-fidelity PCR master mixes, and quantification tools that are widely used in genomics research and clinical diagnostics. Since its acquisition by Roche in 2015, KAPA Biosystems has operated as a key component of Roche Sequencing Solutions, continuing to set industry benchmarks for NGS library construction efficiency.